CN102065875B - 来自荜澄茄的提取物或提取物质作为在用以治疗癌症的药物中的活性成分的用途 - Google Patents

来自荜澄茄的提取物或提取物质作为在用以治疗癌症的药物中的活性成分的用途 Download PDF

Info

Publication number
CN102065875B
CN102065875B CN200880111798XA CN200880111798A CN102065875B CN 102065875 B CN102065875 B CN 102065875B CN 200880111798X A CN200880111798X A CN 200880111798XA CN 200880111798 A CN200880111798 A CN 200880111798A CN 102065875 B CN102065875 B CN 102065875B
Authority
CN
China
Prior art keywords
extract
alcohol
fruit
lipophilic
carcinoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880111798XA
Other languages
English (en)
Chinese (zh)
Other versions
CN102065875A (zh
Inventor
M·-H·克罗伊特
J·Y·任
K·伯格-比特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viridis Pharmaceutical Ltd
Original Assignee
Viridis Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viridis Pharmaceutical Ltd filed Critical Viridis Pharmaceutical Ltd
Publication of CN102065875A publication Critical patent/CN102065875A/zh
Application granted granted Critical
Publication of CN102065875B publication Critical patent/CN102065875B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200880111798XA 2007-08-16 2008-08-15 来自荜澄茄的提取物或提取物质作为在用以治疗癌症的药物中的活性成分的用途 Expired - Fee Related CN102065875B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1289/07 2007-08-16
CH01289/07A CH698627B1 (de) 2007-08-16 2007-08-16 Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.
PCT/CH2008/000350 WO2009021347A1 (de) 2007-08-16 2008-08-15 Verwendung von extrakten oder extraktivstoffen aus piper cubeba l. als wirksame bestandteile in einem medikament zur behandlung von krebserkrankungen

Publications (2)

Publication Number Publication Date
CN102065875A CN102065875A (zh) 2011-05-18
CN102065875B true CN102065875B (zh) 2013-07-17

Family

ID=38668948

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880111798XA Expired - Fee Related CN102065875B (zh) 2007-08-16 2008-08-15 来自荜澄茄的提取物或提取物质作为在用以治疗癌症的药物中的活性成分的用途

Country Status (14)

Country Link
US (3) US8404286B2 (enExample)
EP (1) EP2182966B1 (enExample)
JP (1) JP5378379B2 (enExample)
KR (1) KR20100089815A (enExample)
CN (1) CN102065875B (enExample)
AU (1) AU2008286636B2 (enExample)
BR (1) BRPI0815188A2 (enExample)
CA (1) CA2696499A1 (enExample)
CH (1) CH698627B1 (enExample)
ES (1) ES2392310T3 (enExample)
PL (1) PL2182966T3 (enExample)
RU (1) RU2470657C2 (enExample)
WO (1) WO2009021347A1 (enExample)
ZA (1) ZA201000959B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI472333B (zh) * 2008-06-26 2015-02-11 Piramal Entpr Ltd 治療口腔念珠菌病之口服草本組成物
JP5806231B2 (ja) * 2009-12-21 2015-11-10 アセフ エス．アー． 勃起障害の治療における血管拡張剤としてのクベビン、ジベンジルブチルロラクトリンリグナン、その半合成誘導体および合成誘導体、ならびに他のリグナンおよびネオリグナン
WO2014027857A1 (ko) * 2012-08-16 2014-02-20 부산대학교 산학협력단 알파-이소-쿠베벤 또는 알파-이소-쿠베베놀을 유효성분으로 포함하는 감염성 및 염증성 질환의 예방 또는 치료용 조성물
WO2014086379A1 (en) * 2012-12-03 2014-06-12 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Lignan compositions
FR3085846B1 (fr) * 2018-09-13 2022-01-21 Robertet Sa Utilisation d’extrait de p.nigrum, p. cubeba et/ou s. therebentifolius dans des preparations cosmetiques pour favoriser la pousse des poils
JP7197908B2 (ja) * 2019-03-04 2022-12-28 株式会社ナチュファルマ琉球 骨減少性疾患の予防及び／又は治療用組成物
CN114574286B (zh) * 2022-02-18 2024-03-22 中国热带农业科学院香料饮料研究所 一种具有抗炎活性的胡椒精油及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815177D0 (en) * 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
JP3091962B2 (ja) 1998-09-25 2000-09-25 アルプス薬品工業株式会社 テストステロン−５α−レダクターゼ阻害剤
EP1509204A4 (en) * 2001-11-29 2005-07-13 Rettenmaier & Soehne Gmbh & Co AGGLOMERATED PARTICLES WITH AN ACTIVE SUBSTANCE PREPARED WITH MELTED MICROCRYSTALLINE CELLULOSE
BR0201237A (pt) * 2002-03-25 2003-12-02 Fundacao De Amparo A Pesquisa Processo de obtenção de lignanas dibenzilbutirolactÈnicas, processo de obtenção de derivados sintéticos de lignanas ostentando atividades quimioprofilática e terapêutica antichagásica
US20030228383A1 (en) * 2002-06-06 2003-12-11 J.B. Chemicals & Pharmaceuticals, Ltd. Herbal cough formulations and process for the preparation thereof
JP2004160165A (ja) * 2002-09-17 2004-06-10 Pauretsuku:Kk 生薬成分製剤の造粒方法
CA2512198C (en) * 2002-12-30 2012-06-12 Council Of Scientific And Industrial Research Development of an anti-cough, anti-tussive and throat soothing herbal formulation
JP4319417B2 (ja) * 2003-01-30 2009-08-26 学校法人近畿大学 メラニン産生不全症治療剤
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
(Mrs.)A.Chatterjee等.Spectral Properties of Cubebin.<<JOURNAL OF THE INDIAN CHEMICAL SOCIETY>>.1968,第45卷(第8期),723-725. *
曹玫.荜澄茄中具CYP3A4强抑制作用的成分.<<国外医药-植物药分册>>.2005,第20卷(第6期),252. *

Also Published As

Publication number Publication date
PL2182966T3 (pl) 2013-01-31
US20160193272A1 (en) 2016-07-07
CA2696499A1 (en) 2009-02-19
CN102065875A (zh) 2011-05-18
ZA201000959B (en) 2010-10-27
EP2182966B1 (de) 2012-08-08
US20130251826A1 (en) 2013-09-26
RU2010109750A (ru) 2011-09-27
BRPI0815188A2 (pt) 2015-03-31
JP5378379B2 (ja) 2013-12-25
RU2470657C2 (ru) 2012-12-27
EP2182966A1 (de) 2010-05-12
ES2392310T3 (es) 2012-12-07
KR20100089815A (ko) 2010-08-12
AU2008286636B2 (en) 2013-10-24
WO2009021347A1 (de) 2009-02-19
AU2008286636A1 (en) 2009-02-19
US20110135760A1 (en) 2011-06-09
US9248156B2 (en) 2016-02-02
JP2010536718A (ja) 2010-12-02
CH698627B1 (de) 2009-09-15
US8404286B2 (en) 2013-03-26

Similar Documents

Publication Publication Date Title
CN102065875B (zh) 来自荜澄茄的提取物或提取物质作为在用以治疗癌症的药物中的活性成分的用途
JP2011522822A (ja) エストロゲン受容体β媒介性病状の治療のためのダイオウ（Ｒｈｅｕｍｐａｌｍａｔｕｍ）由来のアントラキノンおよび類似体
US20120045532A1 (en) Anticancer Methods Employing Extracts of Gleditsia sinensis Lam
US20100021574A1 (en) Pharmaceutical Composition and Procedure to Treat and Prevent Prostatic Hyperplasia and Prostatitis from the Royal Palm (Roystonea regia) Fruits
JP2012500776A (ja) ハナスゲａｎｅｍａｒｒｈｅｎａａｓｐｈｏｄｅｌｏｉｄｅｓｂｕｎｇｅの抽出物を使用する抗癌方法
Iweala et al. Cytotoxic Assessment of Xylopia aethiopica [Dun.] A. on Human Prostate and Breast Cancer Cell Lines: doi. org/10.26538/tjnpr/v4i12. 18
ES2979106T3 (es) Uso de oleorresina de copaifera en patologías de la próstata
Ariharasivakumar et al. Chemo preventive potential of Methanolic extract of bark of Albizia lebbeck (L.) benth on n-methyl-n-nitrosourea induced mammary carcinoma in female sprague dawley rats
HK40017918A (en) Use of copaifera oleoresin in pathologies of the prostate
Amira Nour et al. The Effect of Amygdalin in the Treatment of Squamous Cell Carcinoma induced in the Buccal Pouch of Golden Syrian Hamster
HK1084059B (en) Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130717

Termination date: 20140815

EXPY Termination of patent right or utility model